360° Coverage : What Are Bidis And Why Is The FDA Regulating Tobacco Products?

2 Updates

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed...

Filed under: news

 
 
 

33 weeks ago

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed to cease U.S. import, distribution, and sales of four brands of bidis, a tobacco smoking product that’s rolled in the leaves of the tendu plant, instead of paper, then tied with string. The specific bidi products are sold as Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone, and Sutra Bidis Menthol Cone.

An article in The Times of India suggests that Jash International is not a particularly well-known company in its home country, so this first FDA warning might be serving as a shakedown cruise for exercising their regulatory might. The company was cited for not registering their products with the FDA, an application that would likely have been turned down anyway since bidis do not meet the standards of having a “predicate product” sold in the U.S. as of February 15, 2007. What that means is that tobacco products sold as of that date serve as the standard to which new tobacco products are compared with for “substantial equivalence.”

The Act has been criticized in some circles as protecting the large tobacco manufacturers whose previously marketed products serve as such standards.

The FDA’s CTP order results from the authority provided under the Family Smoking Prevention and Tobacco Control Act of 2009, “to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.”

Several local folks I spoke with were not aware that the FDA had regulatory authority of tobacco products, certainly not since 2009. A typical response is “Why would FDA regulate a potentially lethal product?” Indeed, use of tobacco products results in over 440,000 death per year in the U.S. alone.

In the briefest possible terms, the FDA Center for Tobacco Products takes a harm reduction approach to tobacco use in the U.S. The Act established the CTP’s mission as three-fold: 1) to prevent Americans—especially youth—from starting to use tobacco, 2) encourage current users to quit, and 3) decrease the harms of tobacco product use.

To accomplish this mission, the CTP has the authority to require tobacco companies to register their products with the FDA, disclose the content of the product, including nicotine and tar content, limit how tobacco is distributed and sold, and review new tobacco products before they are marketed. Of course, this is one activity where the FDA does not require proof of efficacy or safety. Rather, the products are being regulated to minimize their health risks for Americans who choose to continue smoking.

A major effort is directed at minimizing tobacco sales and promotion to minors, including a ban on all candy and fruit-type flavorings other than menthol. The special dispensation of menthol was a sticking point during legislative deliberations since its inclusion in cigarettes appeals disproportionate to minority groups and causes smoke to be inhaled more deeply into the lungs.

Interestingly, the Act only applies to manufactured or hand-rolled cigarettes, the tobacco used therein, and smokeless tobacco. Cigars do not fall under the Act, nor do the increasingly popular nicotine delivery devices, e-cigarettes.

However, a “Unified Agenda” statement from the FDA and the U.S. Department of Health and Human Services was published in Fall 2013 to give the CTP authority to regulate, “hookah, electronic cigarettes, cigars, pipe tobacco, other novel tobacco products, and future tobacco products.”

The Act represents the compromise from a long battle for complete prohibition of tobacco products that began with the FDA commissioner tenure of Dr. David Kessler from 1990 to 1997.

Kessler documents the history of tobacco regulation in a highly-readable and sometimes suspenseful 2002 book, “A Question of Intent: A Great American Battle With A Deadly Industry.” A Johns Hopkins-trained pediatrician with a University of Chicago law degree, Kessler was not new to politics. He had served as an advisor to Senator Orrin Hatch (R-Utah), who described him in 1991 as, “one of the brightest, most decent men I know.” Kessler had also taught food and drug law at Columbia.

Kessler is well-known to Forbes Pharma & Healthcare readers since his one of his major contributions was to accelerate the pace at which the FDA reviewed and approved pharmaceuticals. Among his accomplishment was to enable the agency to use surrogate endpoints of efficacy as the basis for approval of drugs to treat serious, life-threatening diseases. For example, an increase in CD4+ T lymphocytes was used as a surrogate marker of efficacy of HIV reverse transcriptase inhibitors instead of, say, five-year patient survival.

But Kessler also felt that if nicotine was a drug – which it is in pharmacological terms – and that the FDA regulates all chemicals that come in contact with our bodies, that the FDA should regulate tobacco products. While he was not successful at the time, his efforts carried on as social stigma to tobacco smoke grew across the U.S., even in tobacco-growing states like North Carolina (from where this post has been written).

Passage of the Family Smoking Prevention and Tobacco Control Act of 2009, garnered both bipartisan support, the endorsement of the American Cancer Society and American Heart Association, as well as the endorsement of major tobacco companies. The Act continues to raise concerns as to the ethics of a regulatory safety agency should continue to allow sales of products know to still be the leading cause of death in the United States.

But the Center for Tobacco Products also allows for training and development of policies in this arena. In fact, interested mid-career investigators might care to apply for the third class of FDA-CTP-Institute of Medicine fellowships in tobacco regulatory science. You have one week to send your application in – the deadline is March 3, 2014. Application information is here.

Source: Forbes Business

 
Update
2

7 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slash ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

7 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedies of MH370 and MH17" hits ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

WHO declares Nigeria officially Ebola-free (Roundup)
Abuja/Dar-es-Salam/Tokyo, Oct 20 (IANS) The World Health Organisation (WHO) Monday officially declared Nigeria Ebola-free , after no new cases were confirmed in the past 42 days, even as the International Monetary Fund (IMF) appealed to the donor community to provide grants to countries affected by the deadly virus.
 
 
IMF appeals for help to Ebola-hit countries
Dar-es-Salam, Oct 20 (IANS) The International Monetary Fund (IMF) Monday appealed to the donor community to provide grants to countries affected by the Ebola outbreak to avoid a decline in their economies.
 
 
Japanese firm to produce more drug for Ebola
Tokyo, Oct 20 (IANS) Japan's Fujifilm Holdings Corporation announced Monday that it will start production of the anti-influenza drug Avigan in preparation for a larger number of patients infected with the Ebola virus.
 
 
Algeria denies Ebola detection reports
Algiers, Oct 20 (IANS) Algeria Monday denied reports of detection of Ebola virus cases in its territory, media reported.
 
 
 

Latest from the Network

1,074 new dengue cases in Chinese province
Beijing, Oct 18 (IANS) China's Guangdong province has reported 1,047 new cases of dengue fever, health authorities said Saturday. Six people have already died in Guangdong -- five in Guangzhou and one in adjacent...
Read more on Business Balla
 
Blake Lively 'always' wanted to be mum
Blake Lively has ''always'' wanted to be a mother. The 27-year-old actress is expecting her first child with husband Ryan Reynolds and she admits she's been dreaming of this moment since she was a youngster. Speaking...
Read more on Celebrity Balla
 
Kris Jenner 'torn apart' by Bruce's new relationship
Kris Jenner feels ''torn apart and angry'' that Bruce Jenner is dating her former assistant. The 58-year-old matriarch split from the 64-year-old Olympic gold medalist last October following 22-years of marriage but is...
Read more on Celebrity Balla
 
Cheryl Fernandez-Versini won't move to France
Cheryl Fernandez-Versini doesn't want to move to her husband's home country of France. The 'X Factor' judge, 31, who comes from Newcastle, is adamant she won't be relocating any time soon to suit her new spouse Jean-...
Read more on Celebrity Balla
 
Lance Bass sets wedding date
Lance Bass has set a date for his wedding. The former *NSYNC singer and his partner Michael Turchin, who have been dating for two-and-a-half years, are to tie the knot on December 20, 2014, a representative for the...
Read more on Celebrity Balla
 
Nepal avalanche toll reaches 39
Kathmandu, Oct 18 (IANS) At least 39 climbers died while hiking on a key Nepali route after it was hit by a major snowstorm and avalanches earlier this week, BBC reported Saturday citing officials. Over 350 stranded...
Read more on Politics Balla
 
Jake Gyllenhaal says society is complicit in 'nightcrawling'
Jake Gyllenhaal says almost everybody in society ought to relate to his new movie 'Nightcrawlers'. The eagerly-awaited film concerns those people who monitor police scanners and then race to crime scenes to film eye-...
Read more on Movie Balla
 
India eves look for first win in AFC U-16 qualifiers
Dhaka, Oct 18 (IANS) India will hope to register their first win of the 2015 Asian Football Confederation (AFC) Under-16 Women's Championship qualifiers when they take on hosts Bangladesh in a crucial encounter at the...
Read more on Sport Balla
 
Moyes mulling return to management
London, Oct 18 (IANS) Former Manchester United manager David Moyes said that he is ready to revive his managerial career six months after being sacked by the 'Red Devils'. "I am ready to return. I have enjoyed the...
Read more on Sport Balla
 
Ebola fears loom over Ghana hosting AFCON
Accra (Ghana), Oct 18 (IANS) The Ghana Medical Association (GMA) cautioned the government Saturday against hosting the 2015 African Cup of Nations (AFCON), despite a request by the Confederation of African Football (...
Read more on Sport Balla